Medication regimen complexity of coronary artery disease patients

Marlon Silva Tinoco1, Ronara Camila de Souza Groia-Veloso1, Jéssica Nathália Domingos Dos Santos1

  • 1Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

Insights

High medication regimen complexity in coronary artery disease patients is linked to diabetes mellitus, hypertension, and non-adherence to treatment. Addressing these factors can improve patient management.

Area of Science:

  • Cardiology
  • Pharmacotherapy
  • Public Health

Background:

  • Coronary artery disease (CAD) patients often manage complex medication regimens.
  • High medication complexity can negatively impact treatment adherence and outcomes.
  • Identifying factors contributing to complexity is crucial for effective patient care.

Purpose of the Study:

  • To identify factors associated with high medication regimen complexity in patients with coronary artery disease.
  • To inform strategies for simplifying medication management in this population.

Main Methods:

  • A cross-sectional study was conducted in a cardiology outpatient clinic.
  • Sociodemographic, clinical (comorbidities, diagnoses), and pharmacotherapeutic (adherence, polypharmacy) data were collected.
  • Medication regimen complexity was measured using the Medication Regimen Complexity Index.

Main Results:

  • The study included 148 patients with a median medication regimen complexity of 17.0.
  • Univariate analysis showed associations with heart failure, diabetes mellitus, hypertension, multiple diseases, and non-adherence.
  • Logistic regression identified diabetes mellitus, hypertension, and non-adherence as significant factors (p<0.05).

Conclusions:

  • High medication regimen complexity in CAD patients is significantly associated with diabetes mellitus and hypertension.
  • Non-adherence to treatment is a key factor contributing to medication complexity in this cohort.
  • Targeting these factors may help simplify medication regimens and improve care for CAD patients.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
114
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
87
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
110
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
112
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
461